Epidarex Capital

Investor type

VC / PE

Founded

2010

AUM

$395 M

Location

Bethesda, Maryland, United States

$50-100 m

Investment Ticket

3-5 years

Investment Horizon

Series A, Seed, Late Stage (Series C+)

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.

Industry

Biotechnology Fintech Healthcare Services Medical Devices Pharmaceuticals Financial Services MedTech Technology Life Sciences Infrastructure HealthTech

Region of investment

North America Europe

Epidarex Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Epidarex Capital II
Venture Capital (VC)
Financial Services
Fintech
Healthcare Services
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$47 M
May 2014
Epidarex Capital III
Venture Capital (VC)
Financial Services
Fintech
Healthcare Services
HealthTech
Pre-seed
Seed
North America
$5-10 m
$105 M
June 2020
Epidarex Capital IV
Venture Capital (VC)
Financial Services
Fintech
Healthcare Services
HealthTech
Pre-seed
Seed
North America
$5-10 m
$110 M
January 2026

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
b0jaH7h9d8cDrfJT b0jaH7h9d8cDrfJT
b0jaH7h9d8cDrfJT
avatar
b0jaH7h9d8cDrfJT b0jaH7h9d8cDrfJT
b0jaH7h9d8cDrfJT
avatar
b0jaH7h9d8cDrfJT b0jaH7h9d8cDrfJT
b0jaH7h9d8cDrfJT
avatar
b0jaH7h9d8cDrfJT b0jaH7h9d8cDrfJT
b0jaH7h9d8cDrfJT
avatar
b0jaH7h9d8cDrfJT b0jaH7h9d8cDrfJT
b0jaH7h9d8cDrfJT
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Epidarex Capital

Epidarex Capital is located in Bethesda, Maryland, United States.
Epidarex Capital was founded in 2010.
Epidarex Capital invests in companies and startups in Biotechnology, Fintech, Healthcare Services, Medical Devices, Pharmaceuticals, Financial Services, MedTech, Technology, Life Sciences, Infrastructure, HealthTech.
Epidarex Capital invests in companies and startups in North America, Europe.
Epidarex Capital invests in companies and startups at Series A, Seed, Late Stage (Series C+).
Epidarex Capital usually invests $50-100 m on average.
Epidarex Capital has around $395m assets under management.
Epidarex Capital last fund was created/launched in 2026-01-27